Variant report
Variant | esv3427169 |
---|---|
Chromosome Location | chr6:93268331-93272329 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs76430521 | chr6:93268348-93268349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs190477726 | chr6:93268371-93268372 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs559412717 | chr6:93268445-93268446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs528528045 | chr6:93268446-93268447 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs547194223 | chr6:93268537-93268538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs376869328 | chr6:93268561-93268562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs567323553 | chr6:93268622-93268623 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs530021172 | chr6:93268640-93268641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs549789000 | chr6:93268682-93268683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs569657895 | chr6:93268842-93268843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs565154497 | chr6:93268887-93268888 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs377023026 | chr6:93268968-93268969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs149846384 | chr6:93268994-93268995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs2183001 | chr6:93268997-93268998 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs565789293 | chr6:93269032-93269033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs182753253 | chr6:93269054-93269055 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs187281635 | chr6:93269102-93269103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs73517105 | chr6:93269104-93269105 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs145884984 | chr6:93269149-93269150 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs557368352 | chr6:93269162-93269163 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs368268722 | chr6:93269176-93269177 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs545803185 | chr6:93269187-93269188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs148972859 | chr6:93269192-93269193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs377417795 | chr6:93269232-93269233 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs9452044 | chr6:93269275-93269276 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs567233480 | chr6:93269277-93269278 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs201445421 | chr6:93269282-93269283 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs76097848 | chr6:93269309-93269310 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs561174281 | chr6:93269357-93269358 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs375804299 | chr6:93269423-93269424 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs73517107 | chr6:93269428-93269429 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs569839963 | chr6:93269444-93269445 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs783863 | chr6:93269448-93269449 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs114129754 | chr6:93269451-93269452 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs565650683 | chr6:93269463-93269464 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs564758869 | chr6:93269500-93269501 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs533413203 | chr6:93269527-93269528 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs34022004 | chr6:93269542-93269543 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs534723189 | chr6:93269545-93269546 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs543817266 | chr6:93269578-93269579 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs563803857 | chr6:93269592-93269593 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs183016654 | chr6:93269754-93269755 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs568683875 | chr6:93269773-93269774 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs537239918 | chr6:93269816-93269817 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs117653972 | chr6:93269864-93269865 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs548385629 | chr6:93269876-93269877 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs146439274 | chr6:93269896-93269897 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs140910591 | chr6:93269927-93269928 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs187589937 | chr6:93269928-93269929 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs76943525 | chr6:93269935-93269936 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 21364760 | CNVD |
Developmental delay | 19490664 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Adrenocortical carcinoma | 18281524 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuropathy | 19664229 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:93252400-93268800 | Weak transcription | Fetal Heart | heart |
2 | chr6:93268800-93269200 | Enhancers | Fetal Heart | heart |
3 | chr6:93268800-93269400 | Enhancers | Primary T cells from cord blood | blood |
4 | chr6:93268800-93269600 | Enhancers | Primary hematopoietic stem cells | blood |
5 | chr6:93268800-93270200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
6 | chr6:93269000-93269800 | Enhancers | Primary neutrophils fromperipheralblood | blood |
7 | chr6:93269000-93269800 | Enhancers | HUVEC | blood vessel |
8 | chr6:93269200-93273600 | Weak transcription | Fetal Heart | heart |
9 | chr6:93269400-93269800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |